Trials / Completed
CompletedNCT01091311
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
Phase IV Multicentric Study, 30 Patients Suffering of Meibomian Glands Dysfunction.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction . Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized. This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21. Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Blephasteam | Eye lid warming goggles |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-03-24
- Last updated
- 2011-06-08
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01091311. Inclusion in this directory is not an endorsement.